NR 565 Exam 3: Advanced Pharmacology Fundamentals V3
Updated and Latest Questions and Correct Answers with
Rationale
1. Which of the following is the primary mechanism of action for ACE inhibitors in treating
hypertension?
A. Directly blocking the receptors of angiotensin II
B. Preventing the conversion of angiotensin I to angiotensin II
C. Inhibiting the release of renin from the kidneys
D. Blocking calcium influx into vascular smooth muscle
Ans: B
Rationale: ACE inhibitors block the angiotensin-converting enzyme to prevent the formation of
angiotensin II. This reduction results in systemic vasodilation and decreased blood pressure. These
medications are often used as first-line therapy for hypertensive patients with diabetes. A notable side
effect is the development of a dry cough due to bradykinin. Monitoring potassium levels is necessary as
these drugs can cause hyperkalemia. They are contraindicated during pregnancy because they are known
teratogens.
,2. A patient taking a high-intensity statin reports unexplained muscle pain and dark urine.
Which condition should the nurse practitioner suspect?
A. Acute renal failure due to dehydration
B. Normal side effects of statin therapy
C. Hepatotoxicity from drug metabolism
D. Rhabdomyolysis
Ans: D
Rationale: Rhabdomyolysis is a rare but severe side effect of HMG-CoA reductase inhibitors. It involves
the breakdown of muscle tissue leading to the release of myoglobin. This myoglobin can cause significant
damage to the kidneys if left untreated. Dark, tea-colored urine is a classic sign of this pathological
process. Patients must be educated to report muscle aches or weakness immediately. Laboratory tests for
creatine kinase levels are required to confirm the diagnosis.
3. Which lab value is most critical to monitor for a patient receiving Warfarin therapy?
A. Activated partial thromboplastin time (aPTT)
B. Serum creatinine
C. Platelet count
D. International Normalized Ratio (INR)
Ans: D
Rationale: The INR is the standard measurement used to monitor the effectiveness of Warfarin. It
ensures that the patient’s blood is within the desired therapeutic range for anticoagulation. For most
,patients, a target INR between 2.0 and 3.0 is recommended. Higher values indicate a significant risk for
life-threatening bleeding episodes. Lower values suggest the patient is at risk for developing blood clots.
Consistent monitoring is vital because Warfarin has many drug and food interactions.
4. Metformin is contraindicated in patients with which of the following conditions?
A. Body Mass Index (BMI) over 30
B. Advanced renal impairment (eGFR < 30)
C. History of hypertension
D. Hypertriglyceridemia
Ans: B
Rationale: Metformin carries a black box warning regarding the risk of lactic acidosis. This complication
is most likely to occur in patients with severely impaired renal function. The drug is primarily excreted
unchanged by the kidneys, leading to accumulation. Current guidelines state it should not be used if the
eGFR is below 30. Clinicians must monitor renal function at least annually for all patients on Metformin.
Temporary discontinuation is often required before procedures involving intravenous contrast media.
5. Which beta-blocker is considered cardio-selective, primarily blocking Beta-1 receptors?
A. Propranolol
B. Metoprolol
C. Nadolol
D. Carvedilol
Ans: B
, Rationale: Metoprolol is a selective beta-1 antagonist that primarily affects the heart muscle. By
targeting beta-1 receptors, it reduces heart rate and myocardial contractility. This selectivity makes it
safer for patients with asthma compared to non-selective agents. Non-selective blockers like propranolol
can cause bronchoconstriction by blocking beta-2 receptors. However, selectivity is dose-dependent and
can be lost at higher concentrations. Metoprolol is frequently used to manage hypertension and chronic
heart failure.
6. A patient on Digoxin reports seeing yellow-green halos around lights. This is a classic sign
of:
A. Normal drug effect
B. Acute angle-closure glaucoma
C. Macular degeneration
D. Digoxin toxicity
Ans: D
Rationale: Visual disturbances are hallmark clinical manifestations of Digoxin toxicity in patients.
Yellow-green halos or blurred vision often precede more dangerous cardiac arrhythmias. Hypokalemia
significantly increases the risk of developing this toxic state. The therapeutic window for Digoxin is
narrow, requiring careful serum level monitoring. Digoxin immune fab is the indicated reversal agent for
life-threatening toxicity. Healthcare providers must assess electrolytes and renal function regularly
during therapy.
Updated and Latest Questions and Correct Answers with
Rationale
1. Which of the following is the primary mechanism of action for ACE inhibitors in treating
hypertension?
A. Directly blocking the receptors of angiotensin II
B. Preventing the conversion of angiotensin I to angiotensin II
C. Inhibiting the release of renin from the kidneys
D. Blocking calcium influx into vascular smooth muscle
Ans: B
Rationale: ACE inhibitors block the angiotensin-converting enzyme to prevent the formation of
angiotensin II. This reduction results in systemic vasodilation and decreased blood pressure. These
medications are often used as first-line therapy for hypertensive patients with diabetes. A notable side
effect is the development of a dry cough due to bradykinin. Monitoring potassium levels is necessary as
these drugs can cause hyperkalemia. They are contraindicated during pregnancy because they are known
teratogens.
,2. A patient taking a high-intensity statin reports unexplained muscle pain and dark urine.
Which condition should the nurse practitioner suspect?
A. Acute renal failure due to dehydration
B. Normal side effects of statin therapy
C. Hepatotoxicity from drug metabolism
D. Rhabdomyolysis
Ans: D
Rationale: Rhabdomyolysis is a rare but severe side effect of HMG-CoA reductase inhibitors. It involves
the breakdown of muscle tissue leading to the release of myoglobin. This myoglobin can cause significant
damage to the kidneys if left untreated. Dark, tea-colored urine is a classic sign of this pathological
process. Patients must be educated to report muscle aches or weakness immediately. Laboratory tests for
creatine kinase levels are required to confirm the diagnosis.
3. Which lab value is most critical to monitor for a patient receiving Warfarin therapy?
A. Activated partial thromboplastin time (aPTT)
B. Serum creatinine
C. Platelet count
D. International Normalized Ratio (INR)
Ans: D
Rationale: The INR is the standard measurement used to monitor the effectiveness of Warfarin. It
ensures that the patient’s blood is within the desired therapeutic range for anticoagulation. For most
,patients, a target INR between 2.0 and 3.0 is recommended. Higher values indicate a significant risk for
life-threatening bleeding episodes. Lower values suggest the patient is at risk for developing blood clots.
Consistent monitoring is vital because Warfarin has many drug and food interactions.
4. Metformin is contraindicated in patients with which of the following conditions?
A. Body Mass Index (BMI) over 30
B. Advanced renal impairment (eGFR < 30)
C. History of hypertension
D. Hypertriglyceridemia
Ans: B
Rationale: Metformin carries a black box warning regarding the risk of lactic acidosis. This complication
is most likely to occur in patients with severely impaired renal function. The drug is primarily excreted
unchanged by the kidneys, leading to accumulation. Current guidelines state it should not be used if the
eGFR is below 30. Clinicians must monitor renal function at least annually for all patients on Metformin.
Temporary discontinuation is often required before procedures involving intravenous contrast media.
5. Which beta-blocker is considered cardio-selective, primarily blocking Beta-1 receptors?
A. Propranolol
B. Metoprolol
C. Nadolol
D. Carvedilol
Ans: B
, Rationale: Metoprolol is a selective beta-1 antagonist that primarily affects the heart muscle. By
targeting beta-1 receptors, it reduces heart rate and myocardial contractility. This selectivity makes it
safer for patients with asthma compared to non-selective agents. Non-selective blockers like propranolol
can cause bronchoconstriction by blocking beta-2 receptors. However, selectivity is dose-dependent and
can be lost at higher concentrations. Metoprolol is frequently used to manage hypertension and chronic
heart failure.
6. A patient on Digoxin reports seeing yellow-green halos around lights. This is a classic sign
of:
A. Normal drug effect
B. Acute angle-closure glaucoma
C. Macular degeneration
D. Digoxin toxicity
Ans: D
Rationale: Visual disturbances are hallmark clinical manifestations of Digoxin toxicity in patients.
Yellow-green halos or blurred vision often precede more dangerous cardiac arrhythmias. Hypokalemia
significantly increases the risk of developing this toxic state. The therapeutic window for Digoxin is
narrow, requiring careful serum level monitoring. Digoxin immune fab is the indicated reversal agent for
life-threatening toxicity. Healthcare providers must assess electrolytes and renal function regularly
during therapy.
